{"id":"W4205422786","doi":"10.1016/j.ygyno.2021.12.025","title":"Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck; AstraZeneca","keywords":"Medicine; Olaparib; Clinical endpoint; Internal medicine; Oncology; Adverse effect; Ovarian cancer; BRCA mutation; Tolerability; Progression-free survival; Discontinuation; Progressive disease; Population; Nausea; Chemotherapy; Cancer; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008610321,0.0003276856,0.001153317,0.0006752813,0.0002782915,0.00001290194,0.0002052535,0.0002798394,0.00352997],"category_scores_gemma":[0.0001890806,0.0003177668,0.0002475748,0.0017745,0.0002046046,0.0001147506,0.0001223995,0.0008366773,0.00002516096],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005074488,"about_ca_system_score_gemma":0.000919647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000414511,"about_ca_topic_score_gemma":0.0006209735,"domain_scores_codex":[0.9963952,0.0007812716,0.0009036831,0.0008291636,0.0004801754,0.0006105496],"domain_scores_gemma":[0.9978932,0.0006013763,0.0006505568,0.0004190475,0.0002859774,0.0001498666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01338354,0.005645915,0.8666165,0.00009710408,0.002817749,0.001059766,0.007078984,0.01754081,0.004102091,0.0008288783,0.01127281,0.06955586],"study_design_scores_gemma":[0.03117892,0.004449326,0.9077471,0.00004242465,0.000370112,0.00008937546,0.0007041898,0.003205936,0.0003233405,0.0007048053,0.05066684,0.00051765],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807679,0.0003662602,0.000841031,0.006833976,0.001627216,0.001815444,0.0002427258,0.0001616539,0.007343808],"genre_scores_gemma":[0.9800306,0.0003410545,0.002423115,0.01353447,0.0002104497,0.001717189,0.0008096825,0.00004412569,0.0008893129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0690382,"threshold_uncertainty_score":0.9999275,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02167457305031685,"score_gpt":0.326532917806484,"score_spread":0.3048583447561672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}